N/A N=60 Treatment

Survival and Success of MIS C1 Implants- a Field Study

Failure of Osseointegration of Dental Implant

Bottom Line

View on ClinicalTrials.gov: NCT01707108 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2021

Primary outcome: Primary: Survival Rate — 115 dental implants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Dental Implant (MIS Technologies) (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Rambam Health Care Campus
Primary completion: Oct 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Survival Rate	115	—
SECONDARY 1 Year Implant Bone Level Changes	0.54	—

Summary

The aim of the present study is to evaluate the 1-year and 3-year survival and success of MIS® C1 implants with a length of 10-15mm. Specific Aims 1. To study 1-year and 3-year implant survival rate C1 implants 2. To study 1-year and 3-year implant bone level changes of C1 implants

Eligibility Criteria

Inclusion Criteria

Age between 18-75.
Patient expresses his wish to restore the missing tooth/teeth with implant therapy.
Partial edentulism with available bone height for dental implants ≥ 10mm mm.

Exclusion Criteria

Contraindicating medical conditions such as uncontrolled diabetes, untreated malignancies, pregnancy, previous/current bisphosphonate therapy.
Untreated periodontal disease, untreated caries, periapical pathology in contact with the location of the perspective implant.
Major bone augmentation in conjunction with implant placement. Localised bone augmentation in conjunction with implant placement, of up to 3 mm on 1-2 aspects of the implant will be allowed.
One stage immediate loading/restoration.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01707108). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.